Medherant Ltd - Product Pipeline Analysis, 2019 Update
- GDME2442628PD
- Pages: 32
- November 2019
- Total Views:1130
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormone therapy, and others. Its TEPI patch technology enables the production of patches with effective doses of active ingredients with enhanced long-term drug delivery. Medherant provides high drug loading patches for ibuprofen transdermal and methyl salicylate delivery. The company works in partnership with other companies such as AdhexPharma and Bostik to manufacture TEPI Patch products. It is a spinoff of the University of Warwick. Medherant is headquartered in Coventry, the UK.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Medherant Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents
List of Tables
List of Figures
Medherant Ltd Company Overview
Medherant Ltd Company Snapshot
Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medherant Ltd-Pipeline Analysis Overview
Medherant Ltd-Key Facts
Medherant Ltd-Major Products and Services
Medherant Ltd Pipeline Products by Development Stage
Medherant Ltd Pipeline Products Overview
Cannabinoid TEPI Patch
Cannabinoid TEPI Patch Product Overview
Diclofenac TEPI Patch
Diclofenac TEPI Patch Product Overview
Donepezil TEPI Patch
Donepezil TEPI Patch Product Overview
Dronabinol TEPI Patch
Dronabinol TEPI Patch Product Overview
Ibuprofen TEPI Patch
Ibuprofen TEPI Patch Product Overview
Lidocaine TEPI Patch
Lidocaine TEPI Patch Product Overview
Memantine TEPI Patch
Memantine TEPI Patch Product Overview
Methyl Salicylate TEPI Patch
Methyl Salicylate TEPI Patch Product Overview
TEPI Patch-Alzheimer's Disease
TEPI Patch-Alzheimer's Disease Product Overview
Medherant Ltd-Key Competitors
Medherant Ltd-Key Employees
Medherant Ltd-Locations And Subsidiaries
Head Office
Recent Developments
Medherant Ltd, Recent Developments
Jun 25, 2019: Medherant positions itself for the next stage of its development with the appointment of a new CEO
Jun 25, 2019: Medherant positions itself for the next stage of its development with the appointment of a new CEO
Nov 05, 2018: Medherant announces positive phase I results for its first transdermal drug delivery patch
Oct 03, 2018: Medherant has been awarded a medicines manufacturing grant by Innovate UK
Oct 03, 2018: Innovate UK awards Medherant a medicines manufacturing grant
Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development
Nov 17, 2017: Medherant wins Excellence in Science & Technology Award
Oct 18, 2017: Warwick graduate invents revolutionary device for testing drugs
Sep 26, 2017: Medherant Signs Agreement with Leading Japanese Transdermal Patch Company for Evaluation of Its TEPI Patch Drug Delivery System
Jun 26, 2017: Medherant appoints new COO and CFO
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Figure
List of Figures
Medherant Ltd Pipeline Products by Equipment Type
Medherant Ltd Pipeline Products by Development Stage
List Of Table
List of Tables
Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medherant Ltd Pipeline Products by Equipment Type
Medherant Ltd Pipeline Products by Indication
Medherant Ltd, Key Facts
Medherant Ltd, Major Products and Services
Medherant Ltd Number of Pipeline Products by Development Stage
Medherant Ltd Pipeline Products Summary by Development Stage
Cannabinoid TEPI Patch-Product Status
Cannabinoid TEPI Patch-Product Description
Diclofenac TEPI Patch-Product Status
Diclofenac TEPI Patch-Product Description
Donepezil TEPI Patch-Product Status
Donepezil TEPI Patch-Product Description
Dronabinol TEPI Patch-Product Status
Dronabinol TEPI Patch-Product Description
Ibuprofen TEPI Patch-Product Status
Ibuprofen TEPI Patch-Product Description
Lidocaine TEPI Patch-Product Status
Lidocaine TEPI Patch-Product Description
Memantine TEPI Patch-Product Status
Memantine TEPI Patch-Product Description
Methyl Salicylate TEPI Patch-Product Status
Methyl Salicylate TEPI Patch-Product Description
TEPI Patch-Alzheimer's Disease-Product Status
TEPI Patch-Alzheimer's Disease-Product Description
Medherant Ltd, Key Employees
Glossary
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Medherant Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Nemaura Pharma Ltd
MedPharm Ltd
3M Health Care Ltd
Company Profile
Company Profile Title
Summary
Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormone therapy, and others. Its TEPI patch technology enables the production of patches with effective doses of active ingredients with enhanced long-term drug delivery. Medherant provides high drug loading patches for ibuprofen transdermal and methyl salicylate delivery. The company works in partnership with other companies such as AdhexPharma and Bostik to manufacture TEPI Patch products. It is a spinoff of the University of Warwick. Medherant is headquartered in Coventry, the UK.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Medherant Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Scope
Table of Contents
Table of Contents
List of Tables
List of Figures
Medherant Ltd Company Overview
Medherant Ltd Company Snapshot
Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medherant Ltd-Pipeline Analysis Overview
Medherant Ltd-Key Facts
Medherant Ltd-Major Products and Services
Medherant Ltd Pipeline Products by Development Stage
Medherant Ltd Pipeline Products Overview
Cannabinoid TEPI Patch
Cannabinoid TEPI Patch Product Overview
Diclofenac TEPI Patch
Diclofenac TEPI Patch Product Overview
Donepezil TEPI Patch
Donepezil TEPI Patch Product Overview
Dronabinol TEPI Patch
Dronabinol TEPI Patch Product Overview
Ibuprofen TEPI Patch
Ibuprofen TEPI Patch Product Overview
Lidocaine TEPI Patch
Lidocaine TEPI Patch Product Overview
Memantine TEPI Patch
Memantine TEPI Patch Product Overview
Methyl Salicylate TEPI Patch
Methyl Salicylate TEPI Patch Product Overview
TEPI Patch-Alzheimer's Disease
TEPI Patch-Alzheimer's Disease Product Overview
Medherant Ltd-Key Competitors
Medherant Ltd-Key Employees
Medherant Ltd-Locations And Subsidiaries
Head Office
Recent Developments
Medherant Ltd, Recent Developments
Jun 25, 2019: Medherant positions itself for the next stage of its development with the appointment of a new CEO
Jun 25, 2019: Medherant positions itself for the next stage of its development with the appointment of a new CEO
Nov 05, 2018: Medherant announces positive phase I results for its first transdermal drug delivery patch
Oct 03, 2018: Medherant has been awarded a medicines manufacturing grant by Innovate UK
Oct 03, 2018: Innovate UK awards Medherant a medicines manufacturing grant
Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development
Nov 17, 2017: Medherant wins Excellence in Science & Technology Award
Oct 18, 2017: Warwick graduate invents revolutionary device for testing drugs
Sep 26, 2017: Medherant Signs Agreement with Leading Japanese Transdermal Patch Company for Evaluation of Its TEPI Patch Drug Delivery System
Jun 26, 2017: Medherant appoints new COO and CFO
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Figure
List of Figures
Medherant Ltd Pipeline Products by Equipment Type
Medherant Ltd Pipeline Products by Development Stage
List Of Table
List of Tables
Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medherant Ltd Pipeline Products by Equipment Type
Medherant Ltd Pipeline Products by Indication
Medherant Ltd, Key Facts
Medherant Ltd, Major Products and Services
Medherant Ltd Number of Pipeline Products by Development Stage
Medherant Ltd Pipeline Products Summary by Development Stage
Cannabinoid TEPI Patch-Product Status
Cannabinoid TEPI Patch-Product Description
Diclofenac TEPI Patch-Product Status
Diclofenac TEPI Patch-Product Description
Donepezil TEPI Patch-Product Status
Donepezil TEPI Patch-Product Description
Dronabinol TEPI Patch-Product Status
Dronabinol TEPI Patch-Product Description
Ibuprofen TEPI Patch-Product Status
Ibuprofen TEPI Patch-Product Description
Lidocaine TEPI Patch-Product Status
Lidocaine TEPI Patch-Product Description
Memantine TEPI Patch-Product Status
Memantine TEPI Patch-Product Description
Methyl Salicylate TEPI Patch-Product Status
Methyl Salicylate TEPI Patch-Product Description
TEPI Patch-Alzheimer's Disease-Product Status
TEPI Patch-Alzheimer's Disease-Product Description
Medherant Ltd, Key Employees
Glossary
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Medherant Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Nemaura Pharma Ltd
MedPharm Ltd
3M Health Care Ltd
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 179 | 
February 2020
Page 116 | January 2020
Page 235 | January 2020
Page 183 | September 2019
Page 244 | August 2019